Author: centurium

Beijing, China, July 17, 2019 –– Centurium Capital, a leading private equity firm in China, today announced that Michael Chen had joined the firm as Managing Director. In this new role, Mr. Chen will work closely with Mr. David Li, Chairman and CEO of Centurium Capital, in managing investment activities of the firm.

Mr. Chen has a proven track record as an experienced and successful private equity investor. Before joining Centurium, Mr. Chen was a Managing Director of Warburg Pincus leading its consumer investments in China. During his tenure at Warburg Pincus since 2011, he led a number of investments into leading Chinese companies in transportation and mobility, retail, logistics and education industries.

Mr. Chen commented, “China has come into a new era of real economy and capital market , with both opportunies and challenges. Chinese home-grown private equity firms are well equipped to provide tailor-made solutions for Chinese companies in this new era. With an experienced team, as well as deep sector insights and operational capabilities, Centurium Capital is well postioned to ride this wave and create value for both our portfolio companies and our investors. I’m very excited to join the team and look forward to helping build Centurium into one of the top private equity firms in China.”

Mr. David Li, Chairman and CEO of Centurium Capital, commented, “Michael brings a wealth of expertise and resources through his many years of experience in investment. As the macro trends of consumption upgrade, industry consolidation and technology-driven business innovation continue, Centurium is committed to investing into transformational opportunities to drive portfolio growth. With Michael on board, our investment team is further enhanced, and he will bring tremendous value in our efforts in investment, fundraising and operational suppport to our portfolio companies.”

Prior to joining Warburg Pincus, Mr. Chen was a vice president at Crescent Point, a Pan-Asia growth capital fund. Before Crescent Point, Mr. Chen worked in the investment banking division of Morgan Stanley in Hong Kong and Accenture in China. He received a B.A. of Economics from Fudan University and an M.B.A. from INSEAD.

Centurium Capital is a leading private equity firm in China. With deep domain knowledge and sector resources, Centurium Capital primarily focuses on investing into the China consumer and healthcare sectors. Since its inception, Centurium Capital has received strong support from world-wide leading institutional investors including pension funds, sovereign wealth funds, family offices, corporates and FOFs. The firm seeks to invest in control or significant minority private equity stakes with a particular focus on in-depth engagement to improve operational efficiency and solve structural deficiencies.

Beijing, China, July 3, 2019 – Centurium Capital, a leading private equity firm in China, today announced the successful close of its debut US dollar fund, Centurium Capital Partners 2018 L.P. at over US$2 billion, far exceeding its target size. The fund has secured overwhelming interests from global institutional investors including pension funds, sovereign wealth funds, family offices, corporate pensions, FOFs, and other financial institutions. The fund was launched in March 2018 and reached a significant first close of nearly US$1 billion in June 2018.

Centurium Capital primarily focuses on investing into China’s consumer, services and healthcare sectors. The firm’s investment theses are built around its core investment strategy of “invest to transform”. Centurium seeks to invest in control or significant minority private equity stakes with a particular focus on in-depth engagement to improve operational efficiency and solve structural deficiencies.

David Li, Chairman and CEO of Centurium Capital, commented, “The successful fundraise is a vote of confidence in China’s long term growth potential by global investors, as well as a strong testament to our firm’s strategy and ability of investing to transform. In the context of China’s new norm of economic growth model and fast-evolving business landscape, Chinese companies and entrepreneurs are faced with unprecedented new challenges as well as new opportunities. With a unique combination of global best practice and local expertise and experience, Centurium Capital is well positioned to provide bespoke solutions to these challenges and opportunities by being a long term partner of capital and mindshare to our portfolio companies and entrepreneurs”.

Since its first close, Centurium Capital has made a number of investments, including Luckin Coffee (NASDAQ: LK), a leading internet based on demand coffee brand and retail chain in China, China Biologic Products (NASDAQ: CBPO), one of the largest plasma-based biopharmaceutical companies in China, and LOHO, China’s leading fast-fashion eyewear brand and retailer with a vertically integrated supply chain.